Loading clinical trials...
Loading clinical trials...
This study evaluates the efficacy and safety of coenzyme Q10 supplementation as adjunctive therapy in patients with drug-resistant epilepsy.
Bring this clarity to your next appointment.
Keep all your medical notes and next steps in one place.
Lead Sponsor
National Cheng-Kung University Hospital
NCT02531880 · Epilepsy
NCT06097195 · Epilepsy
NCT06315322 · Childhood Absence Epilepsy, Juvenile Absence Epilepsy
NCT06388707 · Drug Resistant Epilepsy, Epilepsy, and more
NCT07505004 · Focal Epilepsy
National Cheng Kung University Hospital
Tainan
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions